0000000001316388

AUTHOR

Janis Leitans

showing 6 related works from this author

3H-1,2-benzoxathiepine 2,2-dioxides: a new class of isoform-selective carbonic anhydrase inhibitors

2017

Abstract A new chemotype with carbonic anhydrase (CA, EC 4.2.1.1) inhibitory action has been discovered, the homo-sulfocoumarins (3H-1,2-benzoxathiepine 2,2-dioxides) which have been designed considering the (sulfo)coumarins as lead molecules. An original synthetic strategy of a panel of such derivatives led to compounds with a unique inhibitory profile and very high selectivity for the inhibition of the tumour associated (CA IX/XII) over the cytosolic (CA I/II) isoforms. Although the CA inhibition mechanism with these new compounds is unknown for the moment, we hypothesize that it may be similar to that of the sulfocoumarins, i.e. hydrolysis to the corresponding sulfonic acids which therea…

Gene isoformStereochemistryHigh selectivityInhibitory postsynaptic potential01 natural sciencesStructure-Activity RelationshipHydrolysisCarbonic anhydraseDrug DiscoveryHumansMoleculeCarbonic Anhydrase InhibitorsCarbonic AnhydrasesPharmacologyCarbonic anhydraseDose-Response Relationship DrugMolecular Structurebiology010405 organic chemistryChemistrylcsh:RM1-950Active sitehomo-sulfocoumarinsGeneral MedicineCyclic S-Oxides0104 chemical sciencesinhibitor010404 medicinal & biomolecular chemistryCytosollcsh:Therapeutics. PharmacologyBiochemistrysulfocoumarinbiology.proteinResearch PaperJournal of Enzyme Inhibition and Medicinal Chemistry
researchProduct

X-ray crystallography-promoted drug design of carbonic anhydrase inhibitors.

2015

1-N-Alkylated-6-sulfamoyl saccharin derivatives were prepared and assayed as carbonic anhydrase inhibitors (CAIs). During X-ray crystallographic experiments an unexpected hydrolysis of the isothiazole ring was evidenced which allowed us to prepare highly potent enzyme inhibitors with selectivity for some isoforms with medical applications.

DrugModels MolecularStereochemistryProtein Conformationmedia_common.quotation_subjectCrystallography X-RayCatalysisHydrolysischemistry.chemical_compoundCarbonic anhydraseMaterials ChemistryHumansCarbonic Anhydrase Inhibitorsmedia_commonCarbonic Anhydraseschemistry.chemical_classificationIsothiazolebiologyMetals and AlloysGeneral ChemistryLyaseSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsIsoenzymesEnzymechemistryDrug DesignX-ray crystallographyCeramics and Compositesbiology.proteinSelectivityChemical communications (Cambridge, England)
researchProduct

5-Substituted-benzylsulfanyl-thiophene-2-sulfonamides with effective carbonic anhydrase inhibitory activity: Solution and crystallographic investigat…

2017

Abstract A series of 5-substituted-benzylsulfanyl-thiophene-2-sulfonamides was prepared by reacting 5-bromo-thiophene-2-sulfonamide with 5-substituted-benzyl mercaptans. The new compounds were investigated as carbonic anhydrase (CA, EC 4.2.1.1) inhibitors. The cytosolic human (h) isoforms hCA I was poorly inhibited by the new sulfonamides (KIs in the range of 683–4250 nM), whereas hCA II, and the transmembrane, tumor associated isoforms hCA IX and XII were effectively inhibited in the subnanomolar–nanomolar range. A high resolution X-ray crystal structure of the adduct of hCA II with one of the new sulfonamides allowed us to rationalize the excellent inhibitory activity of these heterocycli…

Gene isoformModels MolecularStereochemistryClinical BiochemistryPharmaceutical ScienceCrystal structureThiophenesCrystallography X-Ray01 natural sciencesBiochemistryAdductchemistry.chemical_compoundStructure-Activity RelationshipCarbonic anhydraseDrug DiscoveryThiopheneHumansCarbonic Anhydrase InhibitorsMolecular BiologyCarbonic AnhydrasesSulfonamidesbiologyDose-Response Relationship DrugMolecular Structure010405 organic chemistryOrganic ChemistryLyaseTransmembrane protein0104 chemical sciencesSolutions010404 medicinal & biomolecular chemistryCytosolchemistrybiology.proteinMolecular MedicineBioorganicmedicinal chemistry
researchProduct

Efficient Expression and Crystallization System of Cancer-Associated Carbonic Anhydrase Isoform IX.

2015

Human carbonic anhydrase IX (CA IX) is overexpressed in a number of solid tumors and is considered to be a marker for cellular hypoxia that it is not produced in most normal tissues. CA IX contributes to the acidification of the extracellular matrix, which, in turn, favors tumor growth and metastasis. Therefore, CA IX is considered to be a promising anti-cancer drug target. However, the ability to specifically target CA IX is challenging due to the fact that the human genome encodes 15 different carbonic anhydrase isoforms that have a high degree of homology. Furthermore, structure-based drug design of CA IX inhibitors so far has been largely unsuccessful due to technical difficulties regar…

Gene isoformModels MolecularAntineoplastic AgentsIsozymePichiaPichia pastorisSubstrate SpecificityStructure-Activity RelationshipX-Ray DiffractionAntigens NeoplasmCarbonic anhydraseNeoplasmsDrug DiscoverymedicineStructure–activity relationshipHumansCloning MolecularCarbonic Anhydrase IXCarbonic Anhydrase InhibitorsDatabases ProteinCarbonic Anhydraseschemistry.chemical_classificationbiologyChemistryLyasebiology.organism_classificationAcetazolamideIsoenzymesEnzymeBiochemistrybiology.proteinMolecular MedicineAcetazolamideCrystallizationBaculoviridaemedicine.drugJournal of medicinal chemistry
researchProduct

N-Substituted and ring opened saccharin derivatives selectively inhibit transmembrane, tumor-associated carbonic anhydrases IX and XII.

2017

A series of N-substituted saccharins incorporating aryl, alkyl and alkynyl moieties, as well as some ring opened derivatives were prepared and investigated as inhibitors of the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1). The widespread cytosolic isoforms CA I and II were not inhibited by these sulfonamides whereas transmembrane, tumor-associated ones were effectively inhibited, with KIs in the range of 22.1-481nM for CA IX and of 3.9-245nM for hCA XII. Although the inhibition mechanism of these tertiary/secondary sulfonamides is unknown for the moment, the good efficacy and especially selectivity for the inhibition of the tumor-associated over the cytosolic, widespread isoforms, make…

Gene isoformStereochemistryClinical BiochemistryPharmaceutical Science01 natural sciencesBiochemistrychemistry.chemical_compoundStructure-Activity RelationshipSaccharinAntigens NeoplasmCarbonic anhydraseDrug DiscoveryHumansCarbonic Anhydrase IXCarbonic Anhydrase InhibitorsMolecular BiologyAlkylCarbonic Anhydraseschemistry.chemical_classificationbiologyDose-Response Relationship DrugMolecular Structure010405 organic chemistryArylOrganic ChemistryTransmembrane protein0104 chemical sciences010404 medicinal & biomolecular chemistryCytosolEnzymechemistryBiochemistrybiology.proteinMolecular MedicineSelectivityBioorganicmedicinal chemistry
researchProduct

CCDC 1526002: Experimental Crystal Structure Determination

2017

Related Article: Aleksandrs Pustenko, Dmitrijs Stepanovs, Raivis Žalubovskis, Daniela Vullo, Andris Kazaks, Janis Leitans, Kaspars Tars, Claudiu T. Supuran|2017|J.Enzyme Inhib.Med.Chem.|32|767|doi:10.1080/14756366.2017.1316720

7-nitro-3H-12-benzoxathiepine 22-dioxideSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct